Caisse Des Depots ET Consignations purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 17,298 shares of the company’s stock, valued at approximately $1,660,000.
A number of other large investors have also made changes to their positions in the business. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC increased its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $39,000. UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.
HealthEquity Stock Performance
Shares of NASDAQ HQY opened at $88.83 on Friday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company’s fifty day moving average price is $103.94 and its 200 day moving average price is $95.84. The company has a market capitalization of $7.68 billion, a PE ratio of 81.50, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on HealthEquity
Insider Transactions at HealthEquity
In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.20% of the company’s stock.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- 3 Warren Buffett Stocks to Buy Now
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- How to Capture the Benefits of Dividend Increases
- Top 3 Beverage Stocks Pouring Out Profits
- What Are Treasury Bonds?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.